Atomistry » Zinc » PDB 6kam-6km5 » 6kja
Atomistry »
  Zinc »
    PDB 6kam-6km5 »
      6kja »

Zinc in PDB 6kja: E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain)

Enzymatic activity of E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain)

All present enzymatic activity of E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain):
2.1.3.2;

Protein crystallography data

The structure of E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain), PDB code: 6kja was solved by Z.Lei, J.Zheng, Z.C.Jia, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 42.29 / 3.06
Space group P 32 2 1
Cell size a, b, c (Å), α, β, γ (°) 127.408, 127.408, 197.523, 90.00, 90.00, 120.00
R / Rfree (%) 24.9 / 28.3

Zinc Binding Sites:

The binding sites of Zinc atom in the E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain) (pdb code 6kja). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 3 binding sites of Zinc where determined in the E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain), PDB code: 6kja:
Jump to Zinc binding site number: 1; 2; 3;

Zinc binding site 1 out of 3 in 6kja

Go back to Zinc Binding Sites List in 6kja
Zinc binding site 1 out of 3 in the E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain)


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain) within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn201

b:58.3
occ:1.00
O B:HOH301 2.0 69.2 1.0
SG B:CYS109 2.3 49.6 1.0
SG B:CYS141 2.5 71.7 1.0
SG B:CYS114 2.5 60.1 1.0
SG B:CYS138 2.6 69.8 1.0
CB B:CYS138 3.2 57.5 1.0
CB B:CYS109 3.2 44.9 1.0
CB B:CYS114 3.4 57.6 1.0
CB B:CYS141 3.6 56.1 1.0
N B:CYS141 4.0 51.0 1.0
CA B:CYS141 4.4 53.3 1.0
OG B:SER116 4.6 58.3 1.0
CA B:CYS114 4.6 55.9 1.0
CA B:CYS109 4.6 53.0 1.0
CA B:CYS138 4.7 66.0 1.0
CB B:ASN111 4.7 47.4 1.0
ND2 B:ASN111 4.7 44.5 1.0
CB B:TYR140 5.0 47.6 1.0
CE2 B:PHE125 5.0 86.5 1.0

Zinc binding site 2 out of 3 in 6kja

Go back to Zinc Binding Sites List in 6kja
Zinc binding site 2 out of 3 in the E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain)


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain) within 5.0Å range:
probe atom residue distance (Å) B Occ
D:Zn201

b:66.9
occ:1.00
SG D:CYS109 2.3 59.5 1.0
SG D:CYS141 2.4 48.1 1.0
SG D:CYS114 2.4 61.9 1.0
SG D:CYS138 2.5 53.2 1.0
CB D:CYS138 3.1 59.9 1.0
CB D:CYS114 3.3 66.0 1.0
CB D:CYS141 3.5 47.0 1.0
CB D:CYS109 3.5 66.3 1.0
N D:CYS141 3.9 55.3 1.0
CA D:CYS141 4.3 58.5 1.0
OG D:SER116 4.5 65.3 1.0
CA D:CYS138 4.6 69.7 1.0
CE2 D:PHE125 4.6 52.5 1.0
CA D:CYS114 4.7 52.4 1.0
CB D:TYR140 4.8 46.0 1.0
CB D:ASN111 4.8 52.3 1.0
CA D:CYS109 4.8 58.6 1.0
ND2 D:ASN111 4.8 55.3 1.0
C D:TYR140 5.0 56.8 1.0

Zinc binding site 3 out of 3 in 6kja

Go back to Zinc Binding Sites List in 6kja
Zinc binding site 3 out of 3 in the E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain)


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 3 of E. Coli Atcase Holoenzyme Mutant - G128/130A (Catalytic Chain) within 5.0Å range:
probe atom residue distance (Å) B Occ
F:Zn201

b:48.3
occ:1.00
SG F:CYS109 2.3 66.0 1.0
SG F:CYS141 2.3 44.0 1.0
SG F:CYS114 2.4 49.3 1.0
SG F:CYS138 2.5 46.4 1.0
CB F:CYS138 3.2 48.0 1.0
CB F:CYS114 3.3 42.4 1.0
CB F:CYS109 3.3 52.9 1.0
CB F:CYS141 3.4 45.8 1.0
N F:CYS141 3.8 62.8 1.0
CA F:CYS141 4.2 42.6 1.0
CA F:CYS114 4.6 47.4 1.0
OG F:SER116 4.6 42.1 1.0
CA F:CYS138 4.7 51.9 1.0
CB F:TYR140 4.7 42.2 1.0
CA F:CYS109 4.7 49.2 1.0
CB F:ASN111 4.8 50.4 1.0
ND2 F:ASN111 4.9 42.8 1.0
C F:TYR140 4.9 61.2 1.0
CE1 F:PHE125 5.0 42.8 1.0

Reference:

Z.Lei, B.Wang, Z.Lu, N.Wang, H.Tan, J.Zheng, Z.Jia. New Regulatory Mechanism-Based Inhibitors of Aspartate Transcarbamoylase For Potential Anticancer Drug Development. Febs J. 2020.
ISSN: ISSN 1742-464X
PubMed: 31967710
DOI: 10.1111/FEBS.15220
Page generated: Tue Oct 29 01:47:04 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy